A Phase 1 Trial of the Combination of Perifosine and Docetaxel With or Without Prednisone.
Phase of Trial: Phase I
Latest Information Update: 03 Jun 2015
At a glance
- Drugs Perifosine (Primary) ; Docetaxel; Prednisone
- Indications Cancer
- Focus Adverse reactions
- Sponsors AEterna Zentaris Inc; AOI Pharmaceuticals; Keryx Biopharmaceuticals
- 27 Feb 2013 Lead trial center changed as reported by ClinicalTrials.gov.
- 19 Jul 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 19 Jul 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.